AIRC

Pro-tumorigenic activity of beta-galactosylceramidase: a novel player in cutaneous melanoma

Titolo: Pro-tumorigenic activity of beta-galactosylceramidase: a novel player in cutaneous melanoma Abstract: Background Usually resistant to both chemotherapy and radiotherapy, ...

Caveolin-1 regulates metastatic potential in rhabdomyosarcoma: study on molecular mechanisms and therapeutic strategies

Caveolin-1 regulates metastatic potential in rhabdomyosarcoma: study on molecular mechanisms and therapeutic strategies Responsabile Scientifico per UNIBS: Dott.ssa Silvia Codenotti DMMT ...

Modeling mucosal melanomas. Understanding the immune contexture and the molecular landscape for therapeutic targeting

Modeling mucosal melanomas. Understanding the immune contexture and the molecular landscape for therapeutic targeting Responsabile Scientifico per UNIBS: Prof. William Vermi ...

Progesterone may increase the efficacy of standard chemotherapy plus mitotane in advanced adrenocortical carcinoma

Progesterone may increase the efficacy of standard chemotherapy plus mitotane in advanced adrenocortical carcinoma Responsabile Scientifico per UNIBS: Prof. Alfredo Berruti ...

Long pentraxin 3 (PTX3) as a regulator of lymphangiogenesis and lymphogenous dissemination in melanoma

Long pentraxin 3 (PTX3) as a regulator of lymphangiogenesis and lymphogenous dissemination in melanoma Responsabile Scientifico per UNIBS: Dott. Roberto Ronca ...

Impact of VEGFR2 R1032Q mutation in melanoma progression and pharmacological response

Bando: Borse di studio FIRC-AIRC per l'Italia Responsabile per UniBS: Dott.ssa Margherita di Somma - Dipartimento di Medicina Molecolare e Traslazionale ...

Study of iron and oxidative stress contribution in promoting ferroptosis in hepatocellular carcinoma

Bando: Borse di Studio AIRC per l'Italia Responsabile per UniBS: Dott.ssa Michela Asperti - Dipartimento di Medicina Molecolare e Traslazionale Contatto: ...

FGF/PTX3 cross talk in bladder cancer: novel prognostic and therapeutic implications

Bando: My First AIRC Grant 2016 Responsabile per UniBS: Dott. Roberto Ronca - Dipartimento di Medicina Molecolare e Traslazionale ContaTto: roberto.ronca@unibs.it Data ...

HIV-1 matrix protein p17 and its variants as micoenvironmental factors promoting B-cell lymphomagenesis in AIDS patient

HIV-1 matrix protein p17 and its variants as micoenvironmental factors promoting B-cell lymphomagenesis in AIDS patient Responsabile Scientifico per UNIBS: Prof ...

The atypical chemokine receptor CCRL2/ACKR5 as a new player in carcinogenesis and tumor progression

The atypical chemokine receptor CCRL2/ACKR5 as a new player in carcinogenesis and tumor progression Responsabile Scientifico per UNIBS: Prof. Silvano Sozzani ...

Blocking Fibroblast Growth Factors (FGFs) in Multiple Myeloma: Therapeutic Potential of Extracellular FGF Traps

Bando: Investigator Grant 2016 Responsabile per UniBS: Prof. Marco Presta- Dipartimento di Medicina Molecolare e Traslazionale Contatto: marco.presta@unibs,it Data inizio 02/01/2017 - ...

In Vitro and in vivo assessment of activity of cabazitaxel in adrenocortical carcinoma

Bando: Investigator Grant 2013 Responsabile per UniBS: Prof. Alfredo Berruti - Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica Contatto: alfredo.berruti@unibs.it ...

Characterization of the impact of low frequency mutations in VEGFR2 kinase domain on melanoma progression and response to kinase inhibitor therapy

Bando: Borse di studio AIRC-FIRC per l'Italia Responsabile per UniBS: Dott.ssa Elisabetta Grillo - Dipartimento di Medicina Molecolare e Traslazionale Contatto: ...

FGF/FGFR-targeting anti-angiogenic/anti-tumor therapy for the treatment of uveal melanoma

Bando: Borse di Studio Responsabile per UniBS: Dott.ssa Sara Rezzola - Dipartimento di Medicina Molecolare e Traslazionale Contatto: sara.rezzola@unibs.it Contributo AIRC: € ...